Whalesbook
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]
Business Profile[1]Krsnaa Diagnostics Limited is one of India’s largestdifferentiated diagnostic service providerswith a Pan-India presence in Radiology and Pathology. It has established a Pan India presence through partnerships with government hospitals and operates a substantial number of CT and MRI centers.
| S.No. | Name | Current Price (Rs.) | Price to Earning | Market Capitalization (Rs.Cr.) | Dividend yield (%) | Net Profit latest quarter (Rs.Cr.) | YOY Quarterly profit growth (%) | Sales latest quarter (Rs.Cr.) | YOY Quarterly sales growth (%) | Return on capital employed (%) | Sales (Rs.Cr.) | OPM (%) | Profit after tax (Rs.Cr.) | Profit after tax latest quarter (Rs.Cr.) | Price to book value | Return on assets (%) | Debt to equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Dr Lal Pathlabs | 2995.20 | 46.96 | 25092.44 | 0.80 | 152.20 | 16.41 | 730.60 | 10.66 | 28.88 | 2599.70 | 28.44 | 534.30 | 150.40 | 10.51 | 19.11 | 0.07 |
| 2. | Vijaya Diagnost. | 1001.85 | 67.52 | 10291.50 | 0.20 | 43.28 | 2.75 | 201.56 | 10.17 | 20.91 | 731.83 | 39.81 | 152.42 | 43.28 | 11.90 | 12.29 | 0.42 |
| 3. | Metropolis Healt | 1945.70 | 63.72 | 10083.00 | 0.21 | 52.89 | 13.22 | 429.19 | 22.70 | 14.66 | 1483.31 | 22.40 | 158.23 | 52.67 | 7.04 | 8.24 | 0.14 |
| 4. | Thyrocare Tech. | 433.45 | 54.01 | 6898.86 | 1.61 | 47.81 | 79.94 | 216.53 | 22.09 | 24.78 | 762.64 | 29.86 | 127.73 | 47.99 | 12.90 | 12.86 | 0.05 |
| 5. | Krsnaa Diagnost. | 766.55 | 29.09 | 2486.59 | 0.36 | 23.24 | 5.78 | 182.88 | 2.33 | 12.52 | 698.31 | 29.97 | 85.47 | 23.24 | 2.67 | 6.46 | 0.30 |
| 6. | Suraksha Diagno. | 279.80 | 45.64 | 1457.22 | 0.00 | 8.83 | -13.06 | 78.73 | 17.95 | 17.84 | 275.92 | 30.91 | 31.93 | 8.99 | 6.32 | 9.83 | 0.51 |
| 7. | 3B Blackbio | 1290.75 | 22.56 | 1107.81 | 0.31 | 15.04 | 0.41 | 33.90 | 16.30 | 25.75 | 104.02 | 47.64 | 49.10 | 14.71 | 3.71 | 17.53 | 0.00 |
| – | Median: 11 Co. | 528.45 | 37.37 | 1457.22 | 0.2 | 19.79 | 13.22 | 182.88 | 16.3 | 24.78 | 698.31 | 29.86 | 49.1 | 19.79 | 6.32 | 12.86 | 0.14 |
Standalone figures in ₹ crores
| Dec 2022 | Dec 2023 | Dec 2024 | Jun 2023 | Jun 2024 | Jun 2025 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 116 | 152 | 165 | 132 | 163 | 176 | 116 | 159 | 175 | 121 | 147 | 179 | 183 |
Expenses | 82 | 113 | 117 | 100 | 120 | 126 | 91 | 116 | 121 | 87 | 116 | 126 | 125 |
Operating Profit | 34 | 38 | 48 | 32 | 43 | 50 | 25 | 43 | 53 | 34 | 31 | 52 | 58 |
Other Income | 5 | 4 | 9 | 4 | 7 | 4 | 6 | 4 | 4 | 4 | 4 | 5 | 4 |
Profit before tax | 22 | 17 | 28 | 19 | 24 | 26 | 14 | 22 | 29 | 24 | 14 | 28 | 31 |
Tax % | 24% | 20% | 24% | 18% | 23% | 26% | 17% | 17% | 28% | 24% | 20% | 23% | 24% |
Net Profit | 17 | 14 | 22 | 15 | 18 | 20 | 12 | 18 | 21 | 18 | 11 | 22 | 23 |
EPS in Rs | 5.37 | 4.21 | 6.69 | 4.86 | 5.63 | 6.03 | 3.76 | 5.70 | 6.53 | 5.72 | 3.60 | 6.80 | 7.16 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 36 | 57 | 108 | 147 | 258 | 396 | 455 | 464 | 590 | 682 | 698 |
Expenses | 35 | 42 | 169 | 87 | 373 | 302 | 320 | 340 | 444 | 485 | 489 |
Operating Profit | 0 | 15 | -62 | 60 | -114 | 94 | 135 | 124 | 146 | 197 | 209 |
Other Income | 3 | 4 | 3 | 2 | 13 | 265 | 15 | 19 | 17 | 26 | 22 |
Interest | 6 | 6 | 8 | 16 | 25 | 26 | 18 | 8 | 16 | 25 | 27 |
Depreciation | 5 | 10 | 18 | 26 | 32 | 37 | 41 | 54 | 75 | 88 | 89 |
Profit before tax | -7 | 2 | -84 | 21 | -158 | 295 | 90 | 82 | 72 | 110 | 115 |
Net Profit | -8 | 2 | -60 | 12 | -112 | 185 | 71 | 64 | 59 | 83 | 85 |
EPS in Rs | -15.05 | 4.01 | -116.54 | 24.15 | -216.83 | 284.73 | 22.52 | 20.23 | 18.14 | 25.65 | 26.41 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 11% | 14% | 14% | 11% | – |
Standalone figures in ₹ crores
| Mar 2016 | Mar 2017 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 5 | 6 | 16 | 16 | 16 | 16 | 16 |
Reserves | 4 | 6 | 43 | -217 | -17 | 671 | 727 | 799 | 877 | 916 |
Borrowings | 131 | 102 | 330 | 246 | 474 | 41 | 32 | 160 | 202 | 284 |
Other Liabilities | 24 | 63 | 115 | 596 | 146 | 149 | 134 | 197 | 188 | 287 |
Total Liabilities | 163 | 176 | 493 | 630 | 609 | 877 | 909 | 1,172 | 1,283 | 1,503 |
Fixed Assets | 59 | 116 | 223 | 275 | 309 | 386 | 471 | 647 | 668 | 680 |
Gross Block | 71.69 | 139.15 | 287.16 | 307.51 | 376.51 | 491.35 | 626.62 | 873.65 | 967.90 | – |
Accumulated Depreciation | 13.15 | 23.02 | 64.15 | 32.41 | 68.00 | 105.66 | 155.94 | 226.49 | 300.22 | – |
CWIP | 20 | 6 | 42 | 9 | 4 | 28 | 25 | 10 | 3 | 30 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32 | 32 |
Other Assets | 85 | 53 | 228 | 345 | 297 | 463 | 413 | 514 | 581 | 761 |
Total Assets | 163 | 176 | 493 | 630 | 609 | 877 | 909 | 1,172 | 1,283 | 1,503 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operating Activity | – | 59 | – | 61 | 38 | 119 | 129 | 75 | 24 | 89 |
Cash from Investing Activity | – | -53 | – | -201 | -77 | -67 | -241 | -109 | -129 | -102 |
Cash from Financing Activity | – | -37 | – | 145 | 6 | 20 | 176 | -33 | 84 | 14 |
Net Cash Flow | – | -31 | – | 4 | -33 | 71 | 64 | -66 | -20 | 1 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 87 | 91 | – | 140 | 87 | 69 | 48 | 59 | 110 | 152 |
Inventory Days | 21 | 24 | – | 89 | – | – | – | – | – | – |
Days Payable | 76 | 99 | – | 878 | – | – | – | – | – | – |
Cash Conversion Cycle | 32 | 15 | – | -650 | 87 | 69 | 48 | 59 | 110 | 152 |
Working Capital Days | -428 | -119 | – | -234 | -133 | -82 | -21 | 16 | -18 | 28 |
ROCE % | – | 7% | – | – | -65% | 129% | 18% | 12% | 10% | 13% |
Direct from BSE filings, auto-summarised
External media mentions & references
Editorial & research coverage
Nov 2025
Nov 2025
Aug 2025
May 2025
Feb 2025
Nov 2024
Oct 2024
Aug 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
Jun 2023
Feb 2023
Nov 2022
Aug 2022
Jun 2022
Mar 2022
Feb 2022
Nov 2021
Oct 2021
